Apoptotic dell death through lipid kinase/PKB/AFX and stress signaling pathways
Apoptotic dell death through lipid kinase/PKB/AFX and stress signaling pathways
批准号:
14370059
负责人:
KIKKAWA Ushio
金额:
$9.02万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PKB is a downstream target of PI 3-kinase in the growth factor-signaling pathway. It is proposed that AFX, a forkhead transcription factor, is phosphorylated by PKB, and that AFX localizes in cytosol while phosphorylated and is translocated into cell nucleus, when dephosphorylated, to induce apoptosis. We revealed that two residues of three phosphorylation consensus sites by PKB in AFX, such as Thr32, Ser197, and Ser262, are phosphorylated, and that Ser197 is dephosphorylated immediately after the removal of growth factors in cells by the analysis of point mutants using the phosphorylation site-specific antibodies. On the other hand, we had shown that PKB is activated by heat shock, and thus compared the activation mechanisms of PKB by growth factor and heat shock. It was shown that heat shock generates the active form of PKB in a manner independent of PI 3-kinase without phosphorylation of PKB, which is essential for growth factor-induced activation of the enzyme. It has been established that PKB is recruited to the plasma membrane from cytosol through its PH domain upon growth factor stimulation. In contrast, we revealed that PKB is accumulated in the perinuclear region by the association with Hsp27, a low molecular chaperon protein, in heat-shocked cells. Therefore, PKB is supposed to be activated by different mechanisms to prevent apoptosis by inhibiting the nuclear translocation of AFX. Furthermore, it was shown that PKC, having the catalytic domain highly homologous to that of PKB, is activated by stress signal and enhances apoptosis presumably through the regulation of some lipid metabolizing enzymes. It is necessary to analyze the targets of PKB and PKC in the regulation of stress-induced apoptosis.
期刊论文(62)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Oka, M.: "Dual regulation of phospholipase D1 by protein kinase C α in vivo."Biochem.Biophys.Res.Commun.. 294-5. 1109-1113 (2002)
Oka, M.:“体内蛋白激酶 C α 对磷脂酶 D1 的双重调节”。Biochem.Biophys.Res.Commun. 294-5 (2002)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kazuhiro, Irie: "Establishment of a binding assay for protein kinase C isozymes using synthetic C1 peptides and development of new medicinal leads with protein kinase C isozyme and C1 domain selectivity."Pharmacol.Ther. 93-2,3. 271-282 (2002)
Kazuhiro, Irie:“使用合成 C1 肽建立蛋白激酶 C 同工酶的结合测定,并开发具有蛋白激酶 C 同工酶和 C1 结构域选择性的新药物先导物。”Pharmacol.Ther。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kajimoto, T.: "Ceramide-induced apoptosis by translocation, phosphorylation and activation of protein kinase Cδ at Golgi complex"J.Biol.Chem.. (in press). (2004)
Kajimoto, T.:“高尔基复合体中蛋白激酶 Cδ 的易位、磷酸化和激活导致神经酰胺诱导细胞凋亡”J.Biol.Chem..(出版中)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Irie, K.: "Establishment of a binding assay for protein kinase C isozymes using synthetic C1 peptides and development of new medicinal leads with protein kinase C isozyme and C1 domain selectivity."Pharmacol.Ther.. 93-2,3. 271-282 (2002)
Irie, K.:“使用合成 C1 肽建立蛋白激酶 C 同工酶的结合测定,并开发具有蛋白激酶 C 同工酶和 C1 结构域选择性的新药用先导化合物。”Pharmacol.Ther. 93-2,3。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Hidenori, Matsuzaki: "Distinct activation mechanisms of protein kinase B by growth factor stimulation and heat shock treatment."Biochemistry. 43-14. 4284-4293 (2004)
Hidenori, Matsuzaki:“生长因子刺激和热休克处理对蛋白激酶 B 的独特激活机制。”生物化学。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 27 条
Regulation mechanisms of mTOR-mediated nutrient signaling by protein phosphatase PP2A
-
批准号:20390081
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.56万
-
财政年份:2008
-
负责人:KIKKAWA Ushio
-
依托单位:
Tyrosine phosphorylation and activation of PKC and its role in celluar regulation
-
批准号:10470031
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$6.21万
-
财政年份:1998
-
负责人:KIKKAWA Ushio
-
依托单位:
Regulation of the activity of protein kinases depending on their functional domains
-
批准号:07557200
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$0.9万
-
财政年份:1995
-
负责人:KIKKAWA Ushio
-
依托单位:
Studies on a protein-serine/threonine protein kinase family having a SH2 domain
-
批准号:06454168
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$1.22万
-
财政年份:1994
-
负责人:KIKKAWA Ushio
-
依托单位:
Properties of the delta-, epsilon-, and zeta- Subspecies of Protein Kinase C
-
批准号:03670142
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.34万
-
财政年份:1991
-
负责人:KIKKAWA Ushio
-
依托单位:
国内基金
海外基金
登录
查看更多内容
POSTN 通过Akt/PKB 信号通路促进肝内胆管细胞癌招募肿瘤相关巨噬细胞的作用机制研究
-
批准号:2019JJ80068
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2019
-
负责人:曾杰宏
-
依托单位:
ILK通过调控PKB/Gsk-3β参与Nogo-66抑制轴突再生的机制
-
批准号:81671210
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2016
-
负责人:熊南翔
-
依托单位:
PIPP在小鼠受精卵早期发育过程中对PKB/Akt和PKC的调控
-
批准号:81370712
-
项目类别:面上项目
-
资助金额:70.0万元
-
批准年份:2013
-
负责人:邓欣
-
依托单位:
IGF-1/PI3K/PKB通路介导自噬调控放射性涎腺功能损伤的作用及机制
-
批准号:81371160
-
项目类别:面上项目
-
资助金额:70.0万元
-
批准年份:2013
-
负责人:苏宇雄
-
依托单位:
microRNAs/PI3-K/PKB/GLUT-4信号途径对慢性心衰时骨骼肌糖代谢异常的调控及坎离颗粒干预研究
-
批准号:81273959
-
项目类别:面上项目
-
资助金额:70.0万元
-
批准年份:2012
-
负责人:姚成增
-
依托单位:
PI3K-AKT/PKB介导的团头鲂营养性脂肪肝形成及其营养干预的机制研究
-
批准号:31172418
-
项目类别:面上项目
-
资助金额:56.0万元
-
批准年份:2011
-
负责人:刘文斌
-
依托单位:
PKB/AKT1介导的结核杆菌感染及防治的分子机制研究
-
批准号:30871117
-
项目类别:面上项目
-
资助金额:31.0万元
-
批准年份:2008
-
负责人:范红
-
依托单位:
PKB/Cdc25B途径对小鼠受精卵早期发育调节机制的研究
-
批准号:30800649
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2008
-
负责人:冯晨
-
依托单位:
BTBD10-PP2A-Akt/PKB通路对胰岛β细胞增殖的调控及黄芪多糖的干预机制研究
-
批准号:30873412
-
项目类别:面上项目
-
资助金额:31.0万元
-
批准年份:2008
-
负责人:李春霖
-
依托单位:
胰岛素通过PKB信号通路调控HIF-1α与胰腺癌局部浸润能力的关系
-
批准号:30801098
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2008
-
负责人:刘涛
-
依托单位: